ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug FOG-001 aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new drug called FOG-001 in people with advanced solid tumors (cancers that have spread or can't be removed by surgery). The goal is to see if FOG-001 is safe and can shrink tumors or slow their growth. About 595 adults with cancers like colorectal, prostate, or…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Apr 29, 2026 05:14 UTC
-
Fitbit fitness: could a smartwatch help cancer patients live better?
Symptom relief Recruiting nowThis study tests whether a personalized, automated exercise program using a Fitbit can help people with advanced ovarian or endometrial cancer become more active. Researchers want to see if reaching 150 minutes of moderate exercise per week improves quality of life, physical func…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Apr 29, 2026 05:14 UTC